There’s never been a more exciting time in healthcare, particularly for entrepreneurs. Investment in digital health reached $14.2 billion last year, according to StartUp Health. Life science companies raised $23.3 billion across 1,308 deals, according to the National Venture Capital Association and PitchBook Venture Monitor. Biopharma, diagnostic, medical device and health IT startups are developing innovative approaches to improving quality of care and treatment options.
The MedCity INVEST conference in Chicago April 23-24 offers a forum for companies to present some of their intriguing technologies to a roomful of investors and healthcare stakeholders in one of the largest and most diverse events of its kind in the Midwest. But time is running out to be part of this event.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The deadline to apply for the 2019 competition was Jan. 15 but has been extended to February 8. Click on this link to apply!
In order to participate companies must fulfill at least one of these requirements:
- Raised at least $1 million
- Raised a Series A round
- Have at least one qualified institutional investor or strategic investor that you can identify
Applicants should also be looking for new funding in the next 12 months.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
When filling out the 2-page executive summary portion of the application, please be specific about what you see as the unmet need in the marketplace, your company’s value proposition, how your product works and its underlying technology and your go-to-market strategy. Please also include pilot results or other relevant information you feel sets your startup apart from other applicants.
As a guide, investors will be screening applications based on the following criteria:
- Business Idea
- Market Opportunity
- Revenue Model
- Founder’s Experience
We have confirmed several investors to serve as judges for the competition, and plan to announce more in the coming weeks when they are finalized. They include: Matt McAviney, principal at New Enterprise Associates, Wouter Meuleman, director of venture investments at Illumina Ventures, Adam Koopersmith, partner at Pritzker Group, Nicole Walker, partner at Baird Capital, John Mattison, chief medical information officer and assistant medical director for Kaiser Permanente and Jessica Zeaske, partner with Echo Health Ventures.
Apply today!
Photo: Warchi, Getty Images
